Pay in 4 interest-free payments of $5.66 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Glucagon-like peptide-1 (GLP-1) receptor agonists in inflammatory bowel disease: mechanisms, clinical implications, and therapeutic potential
SGLT2 inhibitors can support modest weight loss (around 23 kg), lower blood pressure, improve heart failure outcomes, and slow the progression of kidney disease
Retatrutide research landscape and what it means for dosing Retatrutide is currently in Phase 3 clinical trials under the Eli Lilly TRIUMPH program
Eligible, with no insurance billing required
US$ 20.86
US$ 23.36
US$ 23.03
US$ 27.92
US$ 21.97
US$ 20.59
US$ 24.37
US$ 24.53
US$ 21.91
